<?xml version="1.0" encoding="UTF-8"?>
<p>Several alterations in DNA methylation associated with PD pathogenesis are described. For example, DNMT1 catalyzing DNA methylation is downregulated in the postmortem brain samples of PD patients [
 <xref rid="B42-biomolecules-11-00624" ref-type="bibr">42</xref>]. Although disputable due to the insufficiency of direct evidence [
 <xref rid="B43-biomolecules-11-00624" ref-type="bibr">43</xref>], those changes may be associated with alterations in the gene expression of Î±-synuclein and other genes implicated in PD development, ultimately causing abnormal protein aggregation [
 <xref rid="B42-biomolecules-11-00624" ref-type="bibr">42</xref>].
</p>
